Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 40.05 CNY -0.84% Market Closed
Market Cap: ¥12.9B

P/B

3.4
Current
5%
Cheaper
vs 3-y average of 3.6

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
3.4
=
Market Cap
¥13.5B
/
Total Equity
¥3.8B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
3.4
=
Market Cap
¥13.5B
/
Total Equity
¥3.8B

Valuation Scenarios

Tibet Rhodiola Pharmaceutical Holding Co is trading below its 3-year average

If P/B returns to its 3-Year Average (3.6), the stock would be worth ¥42.33 (6% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-33%
Maximum Upside
+6%
Average Downside
12%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 3.4 ¥40.05
0%
3-Year Average 3.6 ¥42.33
+6%
5-Year Average 3.6 ¥42.58
+6%
Industry Average 2.3 ¥26.73
-33%
Country Average 2.4 ¥28.86
-28%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
65th
Based on 7 605 companies
65th percentile
3.4
Low
0 — 1.5
Typical Range
1.5 — 3.9
High
3.9 —
Distribution Statistics
China
Min 0
30th Percentile 1.5
Median 2.4
70th Percentile 3.9
Max 1 172 445.9

Tibet Rhodiola Pharmaceutical Holding Co
Glance View

Market Cap
12.9B CNY
Industry
Health Care

Tibet Rhodiola Pharmaceutical Holding Co., nestled in the sprawling and mystical landscape of Tibet, is a beacon of traditional Chinese medicine intertwined with contemporary pharmaceutical practices. The company's genesis lies in the rich, indigenous knowledge of the Rhodiola plant, revered for its supposed adaptogenic properties, which potentially aid in combating stress and fatigue. The plant flourishes in the harsh, high-altitude environment of the Tibetan Plateau, and Tibet Rhodiola has adeptly harnessed both its historical and geographical advantages to cultivate, extract, and process Rhodiola into various health products. These formulations, which range from dietary supplements to wellness solutions, reflect a marriage of ancient herbal wisdom with modern scientific methodologies. Central to the company's business model is its vertically integrated supply chain, which allows it to oversee and control every aspect of production—from the sustainable harvesting of Rhodiola to its research and development ventures. This integration not only ensures quality and efficacy but also fortifies the company's brand as a trustworthy entity within the competitive herbal supplements market. By expanding its distribution channels, Tibet Rhodiola has successfully entered both domestic and international markets, leveraging the rising global enthusiasm for natural and holistic healthcare solutions. This strategic movement feeds directly into its revenue system, which thrives on the growing demand for health products that claim to support vitality and resilience, mirroring the age-old allure of Tibetan medicinal practices.

Intrinsic Value
46.83 CNY
Undervaluation 14%
Intrinsic Value
Price ¥40.05
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett